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Dynein is a motor protein complex that transports various types of intracellular cargos 
from the cell periphery towards the cell center. Dynein mutations are linked to several 
neurodegenerative diseases, including Charcot-Marie-Tooth disease (CMT). A mouse model of 
CMT was generated with a knock-in H304R dynein allele. This mutation at position 304 
corresponds to the H306R mutation found in humans that can cause CMT. Here, a behavioral 
test was developed to study the onset and progression of CMT symptoms in these mice. In the 
tail suspension test, mice were suspended briefly by their tails and the posture of their hind limbs 
was scored. Wildtype mice spread their hind limbs outwards in a characteristic splayed posture, 
whereas heterozygous and homozygous mutants display abnormal phenotypes. 
In further investigation, the neuromuscular junctions of these mice were analyzed in 
order to understand the histological effects of the mutation and how the potential differences 
could result in the behavioral effects observed. The extent of neuromuscular junction innervation 
was examined along with the size and complexity of the neuromuscular junctions themselves 
through multiple criteria. This, when combined with the effects observed during the tail 
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Charcot-Marie-Tooth (CMT) disease is one of the most common neuromuscular disorders, 
encompassing several different hereditary motor and sensory neuropathies. CMT is characterized 
by chronic motor and sensory polyneuropathy, where affected individuals experience distal 
muscle weakness, atrophy associated with sensory loss, and high-arched feet (pes cavus). CMT 
is the most common genetic cause of peripheral neuropathy with a prevalence of about 1 in 1214  
(Braathen, 2012). Patients affected by CMT experience persistent weakness in the hands or feet, 
often requiring special shoes with proper ankle support, forearm crutches for gait stability or 
wheelchairs. Surgical solutions are often required to treat pes cavus. Fatigue can also be severely 
disabling in patients, contributed by weakness in skeletal muscles. This often leads to career and 
employment problems for the patient. (Bird, 1993; El-Abassi et al., 2014). 
CMT type 2O was recently discovered in a large-pedigree family, in which the DYNC1H1 
gene was mutated at position 306, changing a histidine to an arginine in the polypeptide (El-
Abassi et al., 2014; Weedon et al., 2011). This gene encodes for cytoplasmic dynein 1 heavy 
chain 1, a subunit in cytoplasmic dynein. Cytoplasmic dynein is an intracellular motor protein 
that shuttles various cargos from the cell periphery towards the cell center by walking along 
microtubules within cells, moving from the plus end of the microtubule and towards the minus 
end (Schroer et al., 1989). Other mutations in DYNC1H1 have been linked to neurodegenerative 
diseases like SMA-LED (spinal muscular atrophy with lower extremity predominance) with very 
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similar phenotypes to the patients with the H306R mutation causing CMT 2O (Harms et al., 
2012; Tsurusaki et al., 2012).  
Dr. Stephen J. King’s laboratory generated a mutant mouse model that contains a targeted 
knock-in mutation H304R in the DYNC1H1 gene, analogous to the human H306R mutation 
causing CMT 2O. There are other DYNC1H1 mutant mouse models that have been produced, 
most notably the Loa and Cra1 mice. These other mice containing DYNC1H1 mutations exhibit 
defects in retrograde transport. The mutant mouse model generated by Dr. King’s laboratory, 
however, is the first mutation in DYNC1H1 analogous to a known disease-causing mutation in 
humans, whereas Loa and Cra1 are not analogous to human mutations. Homozygous mutant Loa 
and Cra1 mice die within 24 hours of birth (Hafezparast et al., 2003) where H304R homozygous 
mutant mice survive. 
It should be noted that compared to other neurodegenerative diseases, CMT is mild. While 
investigating the more pronounced and obvious effects of the Loa and Cra1 mutations provide 
answers to the functionality of the dynein heavy chain, it does not link back to human disease. 
This suggests that the H304R mouse may be the best disease model to study CMT, because other 
similar mutations are too drastic to properly represent the human disease. Behavioral tests were 
designed in this study to detect the slight changes in fatigue and skeletal muscle weakness in 
H304R mice and the neuromuscular junctions were examined across various mouse ages in order 





PURPOSE AND SIGNIFICANCE 
 
 This research aims to characterize a novel mouse model for CMT2O and determine if it 
can be a successful model for human disease for further research into disease mechanics or 
therapies. This work aims to study the onset and progression of CMT2O symptoms in this mouse 
model by using the developed tail suspension test for fatigue and weakness in the muscles of the 
hind legs. This establishes a timeline for the symptoms observed which can be compared to the 
human disease. Further, studying the neuromuscular junctions of these mice begins to answer the 
question of what is happening in the tissues of these animals and what causes their symptomatic 
behavioral phenotypes. This research seeks to determine if there are characteristic signs in this 
mouse model that point to either a neurodegenerative or neurodevelopmental pathogenesis. After 
establishing a timescale for the onset of disease symptoms through behavioral testing, 
differences observed in the neuromuscular junctions can be compared to the behavioral data to 
investigate the correlation between any changes observed in the neuromuscular junctions and 
disease progression. By understanding what in the tissue is causing the skeletal muscle fatigue 










 Cytoplasmic dynein 1 is a multisubunit molecular motor complex of approximately 1.5 
MDa in size that moves various cargos towards the minus end of microtubules. Cytoplasmic 
dynein’s multiple subunits assemble around a homodimer of heavy chains, which binds to 
microtubules and is responsible for the ATP-driven motor functionality. Dynein moves by taking 
steps and walking along a microtubule using microtubule-binding domains located within the 
dimerized heavy chain. This heavy chain is encoded by a single gene, DYNC1H1. Dynein 
contains two of these identical heavy chain subunits, each of which has a size of approximately 
530 kDa (Pfister et al., 2006). Each heavy chain contains a stem domain at the N-terminus for 
interacting with various cargo and six ATPase domains. Within the stem domain is a region 
responsible for the heavy chain homodimerization (Schiavo et al., 2013). The H306R mutation 
that causes CMT2O is located within the homodimerization region, spanning amino acids 300 – 
1140 (Tynan et al., 2000).  
The housekeeping roles of functional dynein are vital and complete deletions of the 
dynein heavy chain results in embryonic lethality (Harada et al., 1998). The Loa mutant mice 
contain a mutation at position 580 in DYNC1H1, changing a phenylalanine to a tyrosine. The 
Cra1 mice contain a tyrosine to cysteine mutation at position 1055 on the opposite side of the 
homodimerization region. Both the Loa and Cra1 mutations are so damaging to the organism 
that homozygous mutants die within 24 hours of birth. Because the H306R human mutation has 
been linked to CMT2O, it is known that the mutation has an effect in humans. Given the 
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survivability of H304R homozygous mutants however, compared to lethal Loa and Cra1 mice, 
the H304R mutation can be concluded as less disastrous to the organism. This corresponds to the 
human mutation which, while disabling and debilitating, is mild compared to other neuropathies. 
This also points to a new system to study which potentially could be better representative of 





















Aim 1. Characterize the behavioral effects of H304R mutation through hind limb posture 
 
 The other mouse models containing mutations in the DYNC1H1 gene were named for the 
unusual phenotypes animals expressed upon suspension by their tails, Loa (legs at odd angles) 
and Cra1 (Cramping 1) (Hafezparast et al., 2003). Mice in the H304R colony were briefly 
suspended by their tails and heterozygous animals appeared to be more likely to position their 
hind limbs in a manner similar to that observed with the Loa and Cra1 mice. We have 
accordingly designed a behavioral test that examines the different phenotypes observed between 
wildtype, heterozygous and homozygous mutant mice.  
 In the tail suspension test we are using, H304R colony wildtype (+/+), heterozygous 
mutant (+/R) and homozygous mutant (R/R) mice are lifted by their tails from a resting position 
on the experimenter’s hand for ten seconds before being set down again with all four limbs 
settled on the experimenter’s hand. After five seconds of rest, mice are again lifted by their tails 
and suspended for another ten seconds. This process is repeated until the animal has been 
suspended for a total of three times. We believe that this lifting and setting-down of the mice 
tires the animals out faster than simply suspending them for a single thirty-second period and 
exposes a fundamental phenotypic difference in mice of different genotypes. Using two cameras 
connected to a computer, videos are made of all three suspensions from both the ventral and 
lateral angle of the mouse, allowing leg posture to be best assessed. With only one point-of-view, 
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we previously determined that it was difficult to say with any certainty how the animal was 
holding their legs while suspended. For example, while legs may be in close proximity to each 
other from the ventral angle, when observing at the lateral angle they may be held far away from 
the body. These video pairs are then analyzed and each mouse is assigned a score during each of 
the three individual suspensions, depending on how their legs are positioned. Analysis is 
performed without knowledge of the animal’s genotype. Figure 1 shows images from the ventral 
camera showing the three distinct phenotypes observed. A score of 3 indicates that the animal 
has their legs spread and held away from the body in what is the normal response of mice A 
score of 1 indicates that the mouse’s legs are held very tightly to their body, often times touching 
each other. Animals with clasped hind 
limbs are always assigned a score of 1 
because in the observed clasped 
behavior, their limbs are always held 
tightly to their body. A score of 2 
means that the animal’s hind limbs are 
held closer, but the feet are not touching 
each other and the limbs are not tightly 
held to the mouse’s body. A score of 2 corresponds to an intermediate stage. 
 This project seeks to answer two questions. First, using leg posture as an indicator for 
muscle weakness, do the animals exhibit different phenotypes at different rates across the 
genotypes? This would indicate muscle weakness due to the H304R mutation and would make 
Figure 1: Tail Suspension Phenotypes 
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sense given the prevalence of fatigue in skeletal muscles observed with CMT patients. Secondly, 
as the mice age, how do their scores change? This serves to study the onset and progression of 
the disease and examine the course of neurodegeneration over the animal’s lifetime.   
The scores given during the tail suspension behavioral test are not quantitative, rather 
being categorical. Because of this, tests such as the Student’s t-test are not appropriate statistical 
tools for this data. However, because the categories are numbers, averages can be taken in order 
to qualitatively observe changes in the data. Analysis of Figure 2A points out several interesting 
observations. The average first suspension scores and third suspension scores were taken from 
animals of each genotype within each four-week grouping of animals.  The number of tail 
suspensions in each pool ranged from 10 at minimum to a maximum of 147 (male +/R 8 to 11 
weeks) with a tail suspension event in each pool performed by a single animal, with no other 
events in the pool coming from the same animal. The test averages serve to answer the question 
of how animals of each group perform as a whole at each point of the test and how this changes 
over time. For male mice, the distance between +/+ First Score and +/+ Third Score appears 
consistent and smaller than the distance between +/R First Score and +/R Third Score. This 
indicates that the difference in average scores is smaller and over the course of the test and that 
the phenotypes observed changed to more 2’s and 1’s in the +/R male population than the +/+ 
mice. Furthermore, as the animals age, there are more 2’s and 1’s in the +/R male animals during 
the first suspension. Comparing the Third Score of the +/+ male animals and the +/R male 
animals shows a larger difference than comparing the First Scores. This indicates that male +/R 
third suspension scores differ from those of the +/+ males more than the first suspension scores. 
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The difference between the first and third tail suspensions is only that of the time the animal is in 
the third suspension, they are likely to have been more fatigued by the prior two suspensions. 
This means that, with the addition of fatigue as a testing factor, +/R and +/+ animals differ. The 
R/R male animals consistently have lower average scores at all age groups. For both the +/R 
male animals and the R/R male animals, the average score decreases with age.  
The female animals appear to respond to the test in a slightly different manner. In Figure 
2 B, the downward slope of the +/R female mice first and second suspension scores is not as 
steep as it does with the males. While the +/R female scores do not seem to worsen quite to the 
same extent as the +/R male scores, the difference between the +/+ and +/R female scores 
appears similar to that between the +/+ and +/R male scores. The scoring differences with the 
R/R females is obvious and they do appear to have lower scores as the test progresses from the 
first suspension to the third, however the average scores for R/R females does not seem to 
decrease at the same steep rate that does happen with the R/R males. This suggests that there is a 
difference with the progression of disease between the genders, where males have lower average 
scores as they age compared to females. 
The average scores from both the first and third tail suspensions can be seen in Table 1 
for males and Table 2 for females.  Here it is easier to see that the female heterozygous mutants 
have consistently lower scores on the third suspension than the wildtype littermates, though not 
to the same extent that the male heterozygotes differ from wildtype males. Homozygous mutant 





































































































































































































































































Table 1: Average tail suspension scores for male mice  
Male average scores 
age (weeks) 
+/+ +/R R/R 
First Score Third Score First Score Third Score First Score Third Score 
4 to 7 2.93 2.88 2.95 2.92 2.23 2.14 
8 to 11 2.96 2.94 2.94 2.88 2.18 1.87 
12 to 15 2.98 2.94 2.91 2.82 1.91 1.72 
16 to 19 2.93 2.90 2.90 2.80 1.80 1.53 
20 to 23 2.96 2.87 2.86 2.80 1.84 1.47 
24 to 27 2.91 2.90 2.78 2.69 1.69 1.46 
28 to 31 2.91 2.89 2.77 2.63 1.58 1.42 
32 to 35 2.88 2.82 2.73 2.54 1.36 1.27 
36 to 39 2.93 2.87 2.74 2.56 1.40 1.40 
40 to 43 2.83 2.78 2.67 2.46 
  
44 to 47 2.95 2.90 2.69 2.62 
  
48 to 51 2.88 2.80 2.69 2.56 
  
52 to 55 2.92 2.86 2.68 2.56 
  
56 to 59 2.86 2.86 2.64 2.50 
  
60 to 63 2.93 2.83 2.65 2.53 
  










Table 2: Average tail suspension scores for female mice 
Female average scores 
age (weeks) 
+/+ +/R R/R 
First Score Third Score First Score Third Score First Score Third Score 
4 to 7 2.95 2.88 2.93 2.85 2.03 1.90 
8 to 11 2.93 2.87 2.96 2.89 2.14 1.92 
12 to 15 2.88 2.86 2.98 2.83 2.17 1.91 
16 to 19 2.92 2.89 2.89 2.79 2.15 1.85 
20 to 23 2.90 2.88 2.88 2.78 2.05 1.75 
24 to 27 2.87 2.82 2.90 2.72 1.73 1.55 
28 to 31 2.92 2.86 2.87 2.80 2.20 1.90 
32 to 35 2.84 2.84 2.80 2.73 2.00 1.60 
36 to 39 2.88 2.81 2.81 2.80 
  
40 to 43 2.89 2.83 2.72 2.69 
  
44 to 47 2.84 2.81 2.83 2.74 
  
48 to 51 2.83 2.76 2.83 2.65 
  
52 to 55 2.91 2.83 2.80 2.70 
  
56 to 59 2.79 2.69 2.78 2.73 
  










Figure 3 addresses the question of how much the scores change from the first suspension 
to the third suspension.   Here, the average first score subtracted by the average third score for 
each group and this difference is graphed out.  In Figure 3 A, +/+ male animals appear to have a 
consistent difference between their first and third tail suspension scores as they age, while +/R 
male animals have an increase in difference at 20 to 23 weeks (n = 87) that appears to maintain. 
Figure 2 A also shows that after 20 to 23 weeks the +/R male first suspension average score 
becomes lower, though the difference between the scores still remains two to three times more 
than that seen with the +/+ male animals, indicating that more +/R males are starting the test with 
lower scores and even more have lower scores after being fatigued. With the R/R male animals 
though, the score difference rapidly increases at 8 to 11 weeks of age (n = 39) meaning that with 
the addition of fatigue, animals had much lower scores. This trend decreases after 20 to 23 
weeks, in which the average R/R male first suspension score drops but does not get much worse 
by the third suspension. Figure 3 B shows that the +/+ female animals remain consistent in their 
score differences and, for the most part, so do the +/R female animals, although they exhibit a 
larger drop in average score. The drop in average score increases in the R/R female animals, but 
upon examining Figure 2 B it is evident that this is because of an increasingly lower third 
suspension score and not because the first suspension scores are lower. Curiously, the phenotypic 
differences do not appear to become more prevalent as the animals age as seems to be the case 
with the males. 
 Figure 4 shows the individual scoring makeup of each group for the third tail suspension. 
In Figure 4 A, it is clear that the heterozygous male animals have fewer score of 3 as they age, 
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and the score of 1 appears consistently at age 24 to 27 weeks, distinct from similarly aged 
wildtype animals. The drastic scoring difference is also apparent with the homozygous mutant 
animals. In Figure 4 B, the difference between the heterozygous and wildtype female animals is 
far less prominent and does not change as the animals age in the same way the male animals do. 
Although the female homozygous mutant mice have a distinct scoring difference from the other 
genotypes, the scores themselves do not seem to drastically change as the animal ages, as is seen 
with male homozygous mutants. As a whole, female scoring patterns appear to be more 















































































































































Difference between average first suspension score and 



























































































































Difference between average first suspension score and 






















































































































Male score proportions for the third suspension 





















































































































































Female score proportions for the third suspension 




 Because the scoring system was categorical (1, 2 or 3), statistical testing for significance 
was carried out utilizing Pearson’s chi-squared test with the scores from the third tail suspension 
because it shows the greatest difference between heterozygous and wildtype animals. +/+ 
animals were compared to +/R animals to see if this difference observed during the third 
suspension was statistically significant, and R/R animals were compared to both +/+ and +/R 
groups. Results for these statistical tests can be found in Tables 3 and 4. All groups used for 
statistical testing had a minimum n of 10, with no individual animal tested twice within each 
group. 
 At first, the +/R males did not have any significant scoring difference from the wildtype 
littermates. At 12 to 15 weeks age however (n = 131 +/+, 142 +/R) the difference becomes 
significant (P = 0.000549). This trend continues as the heterozygous animals age, with the 
exception of 20 to 23 weeks of age (n = 77 +/+, 87 +/R) where the difference is not significant (P 
= 0.146986). R/R male animals perform significantly differently at all age groups when 
compared to +/+ and +/R male animals. Similarly, R/R female animals perform significantly 
differently than all +/+ and +/R female groups. Interestingly, the female +/R animals only have 
significantly different scores during ages 40 to 43 weeks and 60 to 63 weeks. Figure 4 B shows 
that for those two age groups, +/R animals had only a small proportional increase in the score of 
2.  
 Scores of 3 are the most common among wildtype and heterozygous animals of both 
genders, though heterozygous animals have slightly more scores of 2 and vary rarely scores of 1. 
Score of 1 make up the majority of the scores for homozygous mutant mice. Upon investigation 
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into the frequency of each score, it was found that female wildtype mice tend to have lower third 
suspension scores than their male counterparts; however it is also the higher heterozygous female 
scores that contribute most to the lack of significance when comparing wildtype and 
heterozygous female populations. Figure 2 B illustrates this similarity. 
 In summary, the third tail suspension provides the biggest difference in phenotypes 
amongst any compared group of mice. With males, heterozygous animals performed 
significantly differently from the wildtype animals beginning at age 12 to 15 weeks, with the first 
score of a 1 appearing between 24 and 27 weeks. Homozygous mutants performed significantly 
differently than the other genotypes at all ages. Both male heterozygous and homozygous mutant 
mice populations had lower scores as they aged, while wildtype animals did not change in the 
same manner. In the female mice observed, homozygous mutants had significantly different 
scores than the other genotypes. The heterozygous mutants however did not perform 
significantly differently than the wildtype littermates until 40 to 43 weeks age. No further 
significant difference was observed until 60 to 63 weeks age. Unlike the mutant male mice, 
female mutants do not get lower scores as they age and wildtype animals occasionally have a 
score of 1 during their third suspension. While there does appear to be a consistent different 
between female wildtype and heterozygous average scores, chi-squared analysis does not 






Table 3: Statistical testing of 3
rd
 tail suspension score proportions amongst male mice of different four-week 
age groups and genotypes 
Male results of chi squared test 
age (weeks) +/+ vs +/R +/+ vs R/R +/R vs R/R 
4 to 7 Not Significant Significant Significant 
P = 0.088081512 3.04E-42 1.63E-32 
8 to 11 Not Significant Significant Significant 
P = 0.107896678 1.23E-108 3.73E-116 
12 to 15 Significant Significant Significant 
P = 0.000549252 2.14E-139 3.94E-173 
16 to 19 Significant Significant Significant 
P = 0.007021339 1.50E-245 1.13E-282 
20 to 23 Not Significant Significant Significant 
P = 0.146986208 3.64E-216 2.67E-225 
24 to 27 Significant Significant Significant 
P = 0.003697864 4.91E-30 8.73E-05 
28 to 31 Significant Significant Significant 
P = 0.000173167 2.23E-41 5.26E-56 
32 to 35 Significant Significant Significant 
P = 0.000302072 8.63E-49 5.82E-03 
36 to 39 Significant 
  P = 1.76013E-06 
  40 to 43 Significant 
  P = 1.25892E-05 
  44 to 47 Significant 
  P = 0.00070117 
  48 to 51 Significant 
  P = 0.003110539 
  52 to 55 Significant 
  P = 9.63194E-06 
  56 to 59 Significant 
  P = 1.65768E-06 
  60 to 63 Significant 
  P = 9.11609E-05 
  64 to 67 Significant 
  P = 0.029298294 







Table 4: Statistical testing of score 3
rd
 tail suspension score proportions amongst female mice of different 
four-week age groups and genotypes 
Female results of chi squared test 
age (weeks) +/+ vs +R +/+ vs R/R +/R vs R/R 
4 to 7 Not Significant Significant Significant 
P = 0.536676976 6.20E-62 4.10353E-53 
8 to 11 Not Significant Significant Significant 
P = 0.601110927 5.28E-47 3.75E-39 
12 to 15 Not Significant Significant Significant 
P = 0.193772626 1.36E-61 3.77E-49 
16 to 19 Not Significant Significant Significant 
P = 0.078463766 2.84E-47 2.94E-37 
20 to 23 Not Significant Significant Significant 
P = 0.076023799 7.62E-86 9.34E-69 
24 to 27 Not Significant Significant Significant 
P = 0.084383763 1.71E-22 5.65E-26 
28 to 31 Not Significant Significant Significant 
P = 0.402021383 4.51E-31 3.53E-21 
32 to 35 Not Significant Significant Significant 
P = 0.086133931 4.26287E-06 9.44E-23 
36 to 39 Not Significant 
  P = 0.167851419 
  40 to 43 Significant 
  P = 0.001701135 
  44 to 47 Not Significant 
  P = 0.464145699 
  48 to 51 Not Significant 
  P = 0.154354757 
  52 to 55 Not Significant 
  P = 0.084394188 
  56 to 59 Not Significant 
  P = 0.430081974 
  60 to 63 Significant 
  P = 0.007130928 
  64 to 67 Not Significant 
  P = 0.924719037 






Aim 2. Characterize the neuromuscular junctions of H304R animals 
 
 With a timeline established through behavioral testing as a way to monitor disease onset 
and progression, one obvious next question was to investigate the histological effects of the 
H304R mutation in way that rationally could explain the symptoms observed in human patients 
and the phenotypic changes observed in the tail suspension behavioral test. To answer this 
question, the neuromuscular junctions from sections of the gastrocnemius muscle of +/+ and +/R 
mice were observed and characterized by their structure and the extent of innervation. The 
gastrocnemius muscle is located on the back of the lower leg and is one of two major muscles 
that make up the calf, the other being the soleus muscle. The gastrocnemius is a skeletal muscle 
that attaches to the Achilles tendon in humans. The neuromuscular junction is the region where 
the nervous system connects to the muscular system through synapses. In the neuromuscular 
junctions of skeletal muscles, motor neuron axons extend between folds of the sarcolemma, the 
membrane of the muscle cell. Upon the release of acetylcholine from the motor neurons, skeletal 
muscle cells contract (Sanes and Lichtman, 1999). On the muscle cell around the axon are 
acetylcholine receptors at a density of about 10,000 receptors per micrometer
2
, forming a region 
known as the end plate (Sine, 2012). Studying this interface between the nervous system and the 
muscular system may provide insight into the root cause of the reflex and muscle fatigue 
phenotypes observed in the behavioral test. This further elucidates the pathogenesis of CMT.  
 Normally, the axon from motor neurons completely penetrates the muscle in a complex 
manner with many different branches, completely filling out the space occupied by the 
neuromuscular junction. However, in preliminary investigation it was observed that in H304R 
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mice, some of the neuromuscular junctions were less innervated than others or contained no 
innervation whatsoever. To study the extent of innervation of neuromuscular junctions, each 
neuromuscular junction was sorted into one of three categories - Full, Partial, or None – based on 
how far the stained neurofilament penetrates the junction. The three different categories are 
shown in example in Figure 5. 2H3 is an antibody that recognizes both mouth and rat 
neurofilaments and α-Bungarotoxin is a neurotoxin that binds irreversibly to the nicotinic 
acetylcholine receptor found at the neuromuscular junction. For a neuromuscular junction to 
qualify as fully innervated, the stained neurofilament had to extend into the entire main body of 
the neuromuscular junction, although not every branch from the neuromuscular junction was 
innervated. The difference between partial and full innervations is that in partial innervation, 
some main body regions (or “stems”) are not innervated, whereas with full innervation only 
short, terminal branches are not innervated. In the category without innervation, the 
neurofilament staining still did work and possibly only the base of the neuromuscular junction 
shows signal, but the vast majority of the space of the neuromuscular junction does not appear 
innervated. Only +/+ and +/R male animals were used for the histological portion of this study. 
Tissue was collected from 6 month old animals, 9 month old animals and 12 month old animals. 
 Because of the categorical nature of this analysis, a 2-tailed Pearson’s chi-squared test 
was performed (Table 5). No difference was found in the extent of innervation when comparing 
6 month-old male heterozygous animals to their wildtype littermates (P = 0.3947). At 9 months 
age however, heterozygous males have significantly less innervation than the 9 month old 










Table 5: Results of chi-squared statistical testing on innervation differences in neuromuscular junctions 
 
+/+ 
   
+/R 
  
Chi-squared test of 
significance 
+/+ vs +/R 
 
type # percent 
 
type # percent 
6  
months 
n  = 4 
full 40 47.06% 
6 months 
n  = 4 
full 33 44.59% 
P = 0.3947 
partial 34 40% partial 34 45.95% 





total NMJs 74 
 
 
type # percent 
 




n  = 2 
full 13 65% 
9 months 
n = 2 
full 4 15.38% 
P < 0.0001 
partial 5 25% partial 12 46.15% 





total NMJs 26 
 
 
type # percent 
 




n  = 5 
full 46 55.42% 
12 months 
n  = 4 
full 22 28.95% 
P < 0.0001 
partial 32 38.55% partial 38 50% 













junctions and more neuromuscular junctions without any innervation. Similarly, 12 month old 
male heterozygous mutants differed significantly different from their wildtype littermates (P < 
0.0001) with less fully innervated neuromuscular junctions and more neuromuscular junctions 
without any innervation. This means that starting at 9 months, the neuromuscular junctions in 
heterozygous male animals become less innervated when compared to non-mutant littermates.  
These neuromuscular junctions were also studied by their structures. Table 6 shows the 
results of statistical testing performed on various structural criteria. While Figures 5 and 6 show 
two-dimensional images (maximum projections), these neuromuscular junctions were in fact 
captured through confocal microscopy in a series of z-stacks with 1 micrometer resolution, 
forming three-dimensional image stacks. Because of this, taking the volume and surface area of 
the neuromuscular junctions was possible. As a measure for complexity, the surface area to 
volume ratio was taken for each neuromuscular junction and compared at 6 months, 9 months 
and 12 months for both +/+ and +/R males. As the neuromuscular junctions become thicker or 
shorter (as is depicted in the low surface area / volume column in Figure 6), this ratio is lower, 
while the ratio is higher with more complex and convoluted neuromuscular junctions. The 
surface area to volume ratio was found to be significantly different comparing 6 month old 
heterozygous males to wildtype males (P = 0.0336). The difference is also significant at 9 
months (P < 0.0001) and 12 months (P < 0.0001), with heterozygous males having lower surface 
area to volume ratios than their wildtype counterparts. 
 The specific structural elements of the neuromuscular junctions were also studied through 








Table 6: Results of student’s t-test statistical testing of neuromuscular junction structures 
Average branch length (micrometers) 
           
Group 6+/+ 6+/R 
 
Group 9+/+ 9+/R 
 
Group 12+/+ 12+/R 
Mean 8.96 8.58 
 
Mean 8.30 8.04 
 
Mean 7.84 8.12 
SD 6.06 3.48 
 
SD 2.02 2.48 
 
SD 2.46 2.80 
N 85.00 71.00 
 
N 21.00 26.00 
 
N 102 69 
           
 
P = 0.6303 
  
P = 0.7041 
  
P = 0.5042 
         
Maximum branch length (micrometers) 
           
Group 6+/+ 6+/R 
 
Group 9+/+ 9+/R 
 
Group 12+/+ 12+/R 
Mean 25.40 24.82 
 
Mean 30.43 25.97 
 
Mean 25.39 23.65 
SD 8.97 9.73 
 
SD 11.07 11.76 
 
SD 9.53 9.38 
N 85 71 
 
N 21 26 
 
N 102 69 
           
 
P = 0.7018 
  
P = 0.1913 
  
P = 0.2419 
           
Number of branches 
           
Group 6+/+ 6+/R 
 
Group 9+/+ 9+/R 
 
Group 12+/+ 12+/R 
Mean 18.72 17.39 
 
Mean 25.57 20.15 
 
Mean 22.74 15.23 
SD 8.95 9.72 
 
SD 9.7 11.44 
 
SD 11.77 8.27 
N 85 71 
 
N 21 26 
 
N 102 69 
           
 
P = 0.3780 
  
P = 0.0912 
  
P = 0.0001 
           
Surface area / volume 
           
Group 6+/+ 6+/R 
 
Group 9+/+ 9+/R 
 
Group 12+/+ 12+/R 
Mean 1.87 1.48 
 
Mean 1.69 1.35 
 
Mean 1.68 1.44 
SD 1.52 0.27 
 
SD 0.27 0.21 
 
SD 0.34 0.29 
N 87 74 
 
N 21 26 
 
N 101 85 
           
 
P = 0.0336 
  
P < 0.0001 
  
P < 0.0001 
           Longest shortest path (micrometers) 
           Group 6+/+ 6+/R 
 
Group 9+/+ 9+/R 
 
Group 12+/+ 12+/R 
Mean 67.87 67.34 
 
Mean 85.71 66.55 
 
Mean 76.41 58.38 
SD 22.58 22.20 
 
SD 27.54 19.71 
 
SD 23.80 24.33 
N 85 71 
 
N 21 26 
 
N 102 69 
           
 
P = 0.8837 
  
P = 0.0013 
  
P < 0.0001 
            
28 
 
single skeleton with distinct branches, junctions, and endpoints. Figure 6 shows examples of 
skeletonized neuromuscular junctions. First, in number of branches, the only statistically 
significant difference manifests at 12 months of age (P = 0.0001) in which neuromuscular 
junctions from heterozygous males have on average 15.23 ± 8.27 branches, while wildtype 
neuromuscular junctions have 22.74 ± 11.77. This difference is not present at 6 months or 9 
months of age. For both genotypes and across all age groups, average branch lengths were 
consistently around 8 micrometers. Furthermore, the maximum branch length did not change as 
animals aged, nor did it differ between the genotypes. 
 What did however have a significant difference was the longest shortest path. A shortest 
path is the distance between any two points where a branch ends. The longest shortest path is the 
longest of all the shortest paths in a single skeleton. Figure 6 shows an example of two longest 
shortest paths generated for the two example skeletons, where the longest shortest path is colored 
purple. At 6 months age, there was no difference between the longest shortest path between 
heterozygous males and wildtype littermates. However, there was a significant difference 
between the two genotypes at 9 months age (P = 0.0013) and 12 months age (P < 0.0001) with 
heterozygous males. 
 A conclusion of the analysis of the neuromuscular junctions can be seen in Table 7. At 6 
months age, the neuromuscular junctions from heterozygous males have significantly lower 
surface are to volume ratios. At 9 months age, the neuromuscular junctions from heterozygous 
males are significantly less innervated and have shorter longest shortest paths. At 12 months age, 
the neuromuscular junctions in heterozygous male mice also have a significantly smaller number 
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of branches than the neuromuscular junctions in their wildtype littermates. These data suggest 
that the innervation and structural changes in the neuromuscular junctions of heterozygous 
mutant mice progress over time. Further analysis and interpretation can be found in the 
discussion section. 
 
Table 7: Comparing neuromuscular junction structure between +/R males and +/+ males 
 Innervation Surface area / 
volume 
Number of branches Longest shortest path 
6-month Not Significant Significant Not Significant Not Significant 
9-month Significant Significant Not Significant Significant 














 The tail suspension test was developed because of two reasons. Mice with similar 
mutations in the DYNC1H1 gene were known to have very prominent leg posture phenotypes 
when suspended by their tails. Although the H304R mutation is thought to be less drastic when 
compared to Cra1 and Loa, we initially observed trends with how heterozygous mutant animals 
from the H304R colony held their legs. We subsequently designed a behavioral test, initially 
scoring legs just by their angle relative to their bodies from only a ventral view and suspending 
animals from their tails for one minute. This system was changed by adding a second camera in 
order to get a view from the side of the animal. The test was also changed by adding three tail 
suspensions each lasting fifteen seconds, instead of one minute-long tail suspension. We believe 
that this introduces the factor of fatigue into the test and speculate that the change in phenotype 
from the first to third tail suspension is due to the fatigue that the test gives on the animal. We 
believe that a mouse holding their legs further away from the body while suspended by their tails 
(the normal reflex, score of 3) takes the most energy and is the most physically demanding 
posture. 
 The third tail suspension showed the greatest difference in phenotypes between 
heterozygous mutant males and wildtype littermates. Between ages 12 and 15 weeks, male 
heterozygous mutant animals had significantly different scores than wildtype animals (+/+ 2.94 
average score, +/R 2.81 average score). Further, the average scores for heterozygous males 
continued to lower as the animals aged. This correlates with CMT, where the disease symptoms 
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progress throughout a patient’s life, gradually getting worse. The detection between 12 and 15 
weeks age similarly coincides with the onset of CMT, where patients will usually be diagnosed 
in adolescence or early adulthood. Homozygous mutant males show an even stronger rate of 
change when examining their average scores. 
 Curiously, the behavioral data is different with female mice. The third tail suspension 
scores did not significantly differ between the heterozygous mutant female mice and their 
wildtype littermates until ages 40 to 43 weeks, then 60 to 63 weeks. Behavioral testing will have 
to continue for these mice at later timepoints in order to determine if this infrequent difference is 
the onset of a scoring difference that only affects older mice. Presently, there are too few (n < 10) 
animals in the older female age groups to make any conclusions about their behavioral data. It is 
possible that at later timepoints, female heterozygous mutants would score consistently 
differently than their wildtype littermates in a similar manner to how the male heterozygotes and 
wildtype animals differ. It is also possible that the test itself does not show a phenotype but that 
one is still there, and the onset of disease symptoms can be measured through other criteria. 
 Differences between males and females in neurodegenerative diseases is not 
unprecedented, but is however poorly understood. In Parkinson’s disease, there is a greater 
prevalence and earlier symptomatic onset observed in men. It is believed that the sex hormone 
estradiol provides resilience to loss of dopamine (Gillies et al., 2014). In Alzheimer’s disease, 
several studies show a higher risk in women than men and observational studies show that 
postmenopausal women treated with estrogen had a lower risk (Musicco, 2009). Estrogen 
replacement therapy was similarly investigated as a therapy for amyotrophic lateral sclerosis in 
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women. ALS occurs more in men than in women, and women get the disease later in life than 
men. Postmenopausal women were given estrogen, but no evidence for a neuroprotective role 
was found (Rudnicki, 1999). 
 Neuromuscular junctions have been investigated in many studies on neurodegenerative 
disease. The morphology of the neuromuscular junction has been studied by many different 
methods, most frequently by studying the area of acetylcholine receptor expression as a measure 
of neuromuscular junction size. A study investigating the effects of resistance training on 
neuromuscular junction morphology in rats found that after a 7-week training program, 
neuromuscular junctions examined in two-dimensional images of the soleus muscle (another 
muscle in the calf, lower leg) increased in perimeter by 15% and in area by 16% and 
acetylcholine receptor dispersion was significantly increased (Deschenes et al., 2000). Research 
investigating the structure of neuromuscular junction structure in mice lacking the P2X2 receptor 
(an ion channel receptor subunit expressed during neuromuscular junction development) 
similarly observed acetylcholine receptor expression area in confocal images of the soleus 
muscle (Ryten et al., 2007). Ryten et al. performed their analysis on maximum projections – 
these are two-dimensional images made from a three-dimension stack of images, where the 
maximum pixel value in the z series at a fixed x-y position is kept, generating a map of all the 
maximum intensities. 
The methods used in this research instead measured the expression of the acetylcholine 
receptor in three dimensions using z-stacked images taken through confocal microscopy without 
reducing them to maximum projections. We believe that this allows for a better representation of 
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the space taken up by the neuromuscular junction and allows for better comparisons to be made 
between heterozygous mutants and wildtype littermates. We found that the most informative 
quantitative measurement we not solely comparing surface areas or volumes, but instead 
comparing the ratio between the two. This was done as a way to standardize for variable 
neuromuscular junction sizes and we believe provides a better metric. 
Classifying neuromuscular junctions by the extent of innervation is a fairly common 
technique, but the definitions of each category are not standardized. In a study examining 
synaptic and axonal degeneration in canine motor neuron disease, neuromuscular junctions of the 
gastrocnemius were classified into three categories with respect to innervation: intact, partially 
occupied or denervated (Carrasco et al., 2004). A study using mouse models for Spinal Muscular 
Atrophy examined the morphological characteristics of motor neurons and attempted to link 
different phenotypes to Spinal Muscular Atrophy susceptibility. Here, neuromuscular junctions 
were categorized by innervation as occupied (greater than 50% neuromuscular junction area 
occupied by neurofilament), partially occupied (less than 50%) or vacant (no overlapping) 
(Thomson et al., 2012). The criteria we used to are comparable to the previous ones. Our 
methods grouped neuromuscular junctions into three similar categories. Further, images were 
categorized after rotating the image in all three dimensions in order to best determine the extent 
of innervation rather than relying on a maximum projection or an inaccurate two-dimensional 
image. 
The neuromuscular junctions in heterozygous mutant males had significantly lower 
surface are to volume ratios at 6 months age. At 12 months age, the neuromuscular junctions in 
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heterozygous male mice were also significantly less innervated, had significantly fewer branches 
and a significantly smaller longest shortest path. These data suggest that differences were gained 
as the mice aged, meaning that they started with more wildtype morphologies and gradually 
changed. However, because earlier timepoints were not taken, it cannot be definitively said that 
the surface are to volume ratio difference seen in the 6 month old heterozygous males is the 
result of a neurodevelopmental defect. At the age of 12 to 15 weeks (3 months), the first 
difference in behavioral phenotypes is observed, whereas with earlier ages there was no 
difference.  
Neuromuscular junctions from mice at 3 months age and younger would have to be 
examined in order to investigate the onset of this surface area to volume ratio difference. Further, 
the histological study would have to continue to include the homozygous mutant animals in order 
to best translate the histological observations to the H304R mutation. In cases where only H304R 
mutant dynein is present, what histological effects are observed? How do the heterozygous 
animals compare to the homozygous mutant animals in terms of neuromuscular junction? 
Tissues from female mice at all time points should also be investigated to see how their 
neuromuscular junctions change as they age. Because the behavioral data for the females indicate 
that heterozygous mutants are not significantly different from wildtypes, what do their 
neuromuscular junctions look like? 
Future experiments with more timepoints are required. While results certainly indicate in 
males that heterozygous mutant neuromuscular junctions do change significantly between 6 and 
12 months age when compared to wildtype animals, earlier timepoints are needed to determine 
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the onset of morphological phenotypes and to determine if there are neurodevelopmental 
symptoms of the H304R mutation. 
This research finds that the H304R mutant mouse displays behavioral phenotypes in male 
heterozygotes that correlate with the progression of CMT in humans. The neuromuscular 
junctions of these mice become less innervated as they age (characteristic of neuromuscular 
degeneration) and also have various morphological differences. Further, there is a behavioral 















MATERIALS AND METHODS 
 
 The tail suspension test was performed with +/+, +/R and R/R male and female mice 
beginning at 4 weeks of age. Each individual mouse was only tested once in each 4-week period. 
Mice were suspended by their tails for 15 seconds and then returned to rest on the tester’s hand 
for 5 seconds. This was repeated for a total of 3 suspensions. During the test, two USB computer 
cameras were recording the mouse’s leg posture from two different angles, one ventral to the 
suspended mouse and the other lateral. During analysis, both videos were watched and each of 
the three suspensions was scored a 3, 2, or a 1 depending on leg posture (see Figure 1). All data 
sorting and statistical analysis was performed using custom scripts written in Python, with 
functions for P-value calculation for the chi squared statistical testing coming from the SciPy: 
Open Source Scientific Tools for Python library (Jones et al., 2001--).  
 Cardiac perfusion was performed for all animals used for histological studies. Animals 
were given a lethal dose of Somnasol intraperitoneally. In order to proceed with the cardiac 
perfusion, the efficacy of the anesthesia had to be deemed sufficient through a tail pinch test. 
Before proceeding, it was required that the animal has a lack of response to the tail pinch, in 
addition to slowed breathing movements and a cessation of whisker movements. Upon 
successful anesthesia, a thoracotomy was performed by opening the skin over the thoracic cavity. 
Two incisions were then made bilaterally to the rib cage, and a single incision through the 
diaphragm. While the sternum was held back with a hemostatic clamp, a small needle was 
inserted into the left ventricle while the heart was still beating. Following this, a cut was 
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performed to the right atria to allow blood to be flushed out. Using a perfusion pump, 
approximately 20 mL of 0.9% NaCl solution was perfused, followed by a 0.9% NaCl + 4% 
paraformaldehyde solution to preserve tissues. The gastrocnemius muscle was then removed 
from both legs of the animal and cryopreserved in 30% sucrose overnight. Tissues were then 
embedded in OCT cryoembedding media before being sectioned into 20 µm slices and adhered 
to a slide. These slides were then placed in acetone for 20 minutes at room temperature to fix the 
tissue. Slides are then stored at -20°C until staining. 
 Slides containing muscle sections were washed with phosphate-buffered saline for 10-15 
minutes before being permeabilized for 10 minutes in 0.5% Triton X-100 solution. In a 
humidified chamber, slides were blocked for 1.5 to 2.5 hours in blocking solution (5% bovine 
serum albumin and 0.1% Triton X-100). A mouse 2H3 antibody (staining for neurofilaments) 
was added at a 1:25 dilution into blocking solution, 300 µL per slide. Parafilm was applied over 
the slide and this was allowed to incubate over night at 4°C. Slides were then washed twice with 
blocking solution before applying α-mouse 546 and α-Bungaro toxin-488 (directly stains 
acetylcholine receptors). This stain was applied for 60 minutes before being washed twice with 
blocking solution, washed twice with phosphate-buffered saline. Cover slips were then applied to 
the slides overtop Prolong-Gold with DAPI mounting media. These were allowed to sit overnight 
in a dark environment before nail polish was applied to seal the cover slip. Once dry, they were 
imaged using confocal microscopy. 
 Images of neuromuscular junctions were analyzed using the public domain, Java-based 
image processing program ImageJ (Abramoff, 2004). Images were split into individual channels 
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and innervation was examined through inspecting assembled 3D images of red and green 
channels (neurofilament and acetylcholine receptors). The area and volume of neuromuscular 
junctions were quantified using the 3D Object Counter plugin for ImageJ after applying a binary 
threshold (Bolte and Cordelieres, 2006). Skeletonization of neuromuscular junctions and 
skeleton analysis was performed using the Skeletonize and Analyze Skeleton plugins for ImageJ 
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